Compare EHTH & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EHTH | SEER |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 97.3M |
| IPO Year | 2006 | 2020 |
| Metric | EHTH | SEER |
|---|---|---|
| Price | $1.29 | $1.68 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 826.6K | 254.6K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,395,000.00 | $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | $5.60 | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 45.86 | 16.99 |
| 52 Week Low | $1.20 | $1.62 |
| 52 Week High | $7.09 | $2.41 |
| Indicator | EHTH | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | 40.33 |
| Support Level | $1.20 | N/A |
| Resistance Level | $1.72 | $1.97 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 12.77 | 18.42 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.